摘要
1文献来源Fennell DA,Ewings S,Ottensmeier C,et al.Nivolumab versus placebo in patients with relapsed malignant mesothelioma(CONFIRM):a multicentre,double-blind,randomised,phase 3 trial[J].Lancet Oncol,2021,22(11):1530-1540.2证据水平1b。
作者
卫静文
宋正波
WEI Jing-wen;SONG Zheng-bo(Department of Clinical Trial,Zhejiang Cancer Hospital,Hangzhou Institute of Medicine(HIM),Chinese Academy of Sciences,Postgraduate Training Base Alliance of Wenzhou Medical University(Zhejiang Cancer Hospital),Hangzhou 310022,China)
出处
《循证医学》
2023年第5期268-272,共5页
The Journal of Evidence-Based Medicine
